Understanding the dengue viruses and progress towards their control

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Rodriguez Roche, Rosmari ^a   Gould, Ernest A ^b,c  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^b Aix Marseille University IRD 190 Inserm 1207   (France)

^c CENTRE FOR ECOLOGY AND HYDROLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC G 418; ANTIVIRUS AGENT; AZAURIDINE; BOESENBERGIA ROTUNDA EXTRACT; CARBAMIC ACID; DENGUE VACCINE; DOXORUBICIN; FAVIPIRAVIR; INSECT REPELLENT; INSECTICIDE; INTERFERON; IVERMECTIN; LIVE VACCINE; MYCOPHENOLIC ACID; NUCLEOSIDE ANALOG; NUCLEOSIDE TRIPHOSPHATE; PIRAZOFURIN; PLANT EXTRACT; RIBAVIRIN; SUBUNIT VACCINE; UNCLASSIFIED DRUG; NS2A PROTEIN, DENGUE VIRUS TYPE 2; VIRUS PROTEIN;

ABDOMINAL PAIN; AEDES AEGYPTI; ANTIVIRAL ACTIVITY; ANTIVIRAL THERAPY; ARTHRALGIA; ARTICLE; BED NET; BLEEDING; BOESENBERGIA ROTUNDA; CLINICAL CLASSIFICATION; CLINICAL FEATURE; CRYSTALLOID; DENGUE; DENGUE VIRUS; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; DISEASE CONTROL; DISEASE COURSE; EPIDEMIC; FLAVIVIRUS; GENETIC VARIABILITY; GENOTYPE; HEADACHE; HEMAGGLUTINATION INHIBITION; HEMATEMESIS; HEPATOMEGALY; HUMAN; IMMUNE STATUS; INCIDENCE; INFECTION RESISTANCE; INFECTION RISK; LETHARGY; MACULOPAPULAR RASH; MEDICINAL PLANT; MIXED INFECTION; MOSQUITO; MUCOSAL BLEEDING; MYALGIA; NONHUMAN; PATHOGENESIS; POPULATION GENETICS; PRIMARY PREVENTION; RESTLESSNESS; SECONDARY INFECTION; THROMBOCYTOPENIA; VECTOR CONTROL; VIRUS VIRULENCE; VOMITING; WEAKNESS; WORLD HEALTH ORGANIZATION; GENETICS; PATHOGENICITY; PATHOLOGY; TROPICAL MEDICINE; VIROLOGY; REVIEW;

DENGUE; DENGUE VIRUS; EPIDEMICS; HUMANS; TROPICAL MEDICINE; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84880853618     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/690835     Document Type: Article

References (278)

1. Pinheiro F. P., Corber S. J., Global situation of dengue and dengue haemorrhagic fever, and its emergence in the Americas. World Health Statistics Quarterly 1997 50 3-4 161 169 2-s2.0-0031418454 (Pubitemid 28133355)
2. Gubler D. J., The global emergence/resurgence of arboviral diseases as public health problems. Archives of Medical Research 2002 33 4 330 342 2-s2.0-0036662182 10.1016/S0188-4409(02)00378-8 (Pubitemid 35299553)
3. Halstead S. B., Dengue. The Lancet 2007 370 9599 1644 1652 2-s2.0-35748929379 10.1016/S0140-6736(07)61687-0 (Pubitemid 350052290)
4. De A. Zanotto P. M., Gould E. A., Gao G. F., Harvey P. H., Holmes E. C., Population dynamics of flaviviruses revealed by molecular phylogenies. Proceedings of the National Academy of Sciences of the United States of America 1996 93 2 548 553 2-s2.0-0009650916 10.1073/pnas.93.2.548 (Pubitemid 26041125)
5. WHO, Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control 1997 2nd Geneva, Switzerland WHO
6. Ling L. M., Wilder-Smith A., Leo Y. S., Fulminant hepatitis in dengue haemorrhagic fever. Journal of Clinical Virology 2007 38 3 265 268 2-s2.0-33847101469 10.1016/j.jcv.2006.12.011 (Pubitemid 46290701)
7. Gulati S., Maheshwari A., Atypical manifestations of dengue. Tropical Medicine and International Health 2007 12 9 1087 1095 2-s2.0-34548785576 10.1111/j.1365-3156.2007.01891.x (Pubitemid 47421842)
8. Kumar R., Tripathi S., Tambe J. J., Arora V., Srivastava A., Nag V. L., Dengue encephalopathy in children in Northern India: clinical features and comparison with non dengue. Journal of the Neurological Sciences 2008 269 1-2 41 48 2-s2.0-43049114145 10.1016/j.jns.2007.12.018
9. Wasay M., Channa R., Jumani M., Shabbir G., Azeemuddin M., Zafar A., Encephalitis and myelitis associated with dengue viral infection. Clinical and neuroimaging features. Clinical Neurology and Neurosurgery 2008 110 6 635 640 2-s2.0-44449105163 10.1016/j.clineuro.2008.03.011
10. Solomon T., Dung N. M., Vaughn D. W., Kneen R., Thao L. T. T., Raengsakulrach B., Loan H. T., Day N. P. J., Farrar J., Myint K. S. A., Warrell M. J., James W. S., Nisalak A., White N. J., Neurological manifestations of dengue infection. The Lancet 2000 355 9209 1053 1059 2-s2.0-0034712444 (Pubitemid 30162808)
11. Park S. B., Ryu S. Y., Jin K. B., Hwang E. A., Han S. Y., Kim H. T., Cho W. H., Kwak J. H., Ahn K. S., Kim H. C., Acute colitis associated with dengue fever in a renal transplant recipient. Transplantation Proceedings 2008 40 7 2431 2432 2-s2.0-51249114979 10.1016/j.transproceed.2008.07.037
12. Balmaseda A., Hammond S. N., Pérez M. A., Cuadra R., Solano S., Rocha J., Idiaquez W., Harris E., Short report: assessment of the World Health Organization scheme for classification of dengue severity in Nicaragua. The American Journal of Tropical Medicine and Hygiene 2005 73 6 1059 1062 2-s2.0-29844433013 (Pubitemid 43038254)
13. Bandyopadhyay S., Lum L. C. S., Kroeger A., Classifying dengue: a review of the difficulties in using the WHO case classification for dengue haemorrhagic fever. Tropical Medicine and International Health 2006 11 8 1238 1255 2-s2.0-33746429601 10.1111/j.1365-3156.2006.01678.x (Pubitemid 44125713)
14. Rigau-Pérez J. G., Severe dengue: the need for new case definitions. Lancet Infectious Diseases 2006 6 5 297 302 2-s2.0-33646050927 10.1016/S1473-3099(06)70465-0
15. Deen J. L., Harris E., Wills B., Balmaseda A., Hammond S. N., Rocha C., Dung N. M., Hung N. T., Hien T. T., Farrar J. J., The WHO dengue classification and case definitions: time for a reassessment. The Lancet 2006 368 9530 170 173 2-s2.0-33745633312 10.1016/S0140-6736(06)69006-5 (Pubitemid 43994174)
16. Alexander N., Balmaseda A., Coelho I. C. B., Dimaano E., Hien T. T., Hung N. T., Jäenisch T., Kroeger A., Lum L. C. S., Martinez E., Siqueira J. B., Thuy T. T., Villalobos I., Villegas E., Wills B., Multicentre prospective study on dengue classification in four South-east Asian and three Latin American countries. Tropical Medicine and International Health 2011 16 8 936 948 2-s2.0-79960210742 10.1111/j.1365-3156.2011.02793.x
17. WHO/TDR, Dengue Guidelines for Diagnosis, Treatment, Prevention and Control 2009 Geneva, Switzerland WHO Press
18. Akbar N. A., Allende I., Balmaseda A., Regarding "Dengue-how best to classify it" Clinical Infectious Diseases 2012 54 12 1820 1821. author reply 1821-1822 10.1093/cid/cis328
19. Srikiatkhachorn A., Rothman A. L., Gibbons R. V., Sittisombut N., Malasit P., Ennis F. A., Nimmannitya S., Kalayanarooj S., Dengue-how best to classify it. Clinical Infectious Diseases 2011 53 6 563 567 2-s2.0-80052191667 10.1093/cid/cir451
20. Kalayanarooj S., Dengue classification: current WHO vs. The newly suggested classification for better clinical application? Journal of the Medical Association of Thailand 2011 94 S74 84 2-s2.0-84856315951
21. Halstead S. B., Dengue: the syndromic basis to pathogenesis research. Inutility of the 2009 WHO case definition. The American Journal of Tropical Medicine and Hygiene 2013 88 2 212 215 10.4269/ajtmh.12-0197
22. Reinert J. F., Harbach R. E., Kitching I. J., Phylogeny and classification of Ochlerotatus and allied taxa (Diptera: Culicidae: Aedini) based on morphological data from all life stages. Zoological Journal of the Linnean Society 2008 153 1 29 114 2-s2.0-42649106147 10.1111/j.1096-3642.2008. 00382.x (Pubitemid 351594987)
23. Reinert J. F., Harbach R. E., Kitching I. J., Phylogeny and classification of Aedini (Diptera: Culicidae), based on morphological characters of all life stages. Zoological Journal of the Linnean Society 2004 142 3 289 368 2-s2.0-8844249401 10.1111/j.1096-3642.2004.00144.x (Pubitemid 39533588)
24. Reinert J. F., Harbach R. E., Kitching I. J., Phylogeny and classification of Finlaya and allied taxa (Diptera: Culicidae: Aedini) based on morphological data from all life stages. Zoological Journal of the Linnean Society 2006 148 1 1 101 2-s2.0-33748371201 10.1111/j.1096-3642.2006.00254.x (Pubitemid 44337265)
25. Gould E. A., de Lamballerie X., Zanotto P. M. D. A., Holmes E. C., Origins, evolution, and vector{plus 45 degree rule}host coadaptations within the Genus Flavivirus. Advances in Virus Research 2003 59 277 314 2-s2.0-1542571418 10.1016/S0065-3527(03)59008-X (Pubitemid 137639368)
26. Strode G. K., Yellow Fever 1951 New York, NY, USA McGraw-Hill
27. Tabachnick W. J., Evolutionary genetics and arthropod-borne diseases. The yellow fever mosquito, Aedes aegypti. American Journal of Entomology 1991 37 14 24
28. Lounibos L. P., Invasions by insect vectors of human disease. Annual Review of Entomology 2002 47 233 266 2-s2.0-0036006831 10.1146/annurev.ento.47. 091201.145206 (Pubitemid 34108582)
29. De Lamballerie X., Leroy E., Charrel R. N., Ttsetsarkin K., Higgs S., Gould E. A., Chikungunya virus adapts to tiger mosquito via evolutionary convergence: a sign of things to come? Virology Journal 2008 5, article 33 2-s2.0-40749142449 10.1186/1743-422X-5-33 (Pubitemid 351389092)
30. Tatem A. J., Snow R. W., Hay S. I., Mapping the environmental coverage of the INDEPTH demographic surveillance system network in rural Africa. Tropical Medicine and International Health 2006 11 8 1318 1326 2-s2.0-33746437594 10.1111/j.1365-3156.2006.01681.x (Pubitemid 44125720)
31. Bloom K. J., The Mississippi Valley's Great Yellow Fever Epidemic of 1978 1993 Baton Rouge, Lo, USA Louisiana State University Press
32. Rush B., An account of the bilious remitting fever. As it appeared in philadelphia, in the summer and autumn of the year 1780. The American Journal of Medicine 1951 11 5 546 550 2-s2.0-50449117701
33. Halstead S. B., Dengue in the Americas and Southeast Asia: do they differ? Revista Panamericana de Salud Publica 2006 20 6 407 415 2-s2.0-34247180020 (Pubitemid 46625742)
34. Gubler D., Gubler D., Kuno G., Dengue and dengue hemorrhagic fever: its history and resurgence as a global public health problem. Dengue and Dengue Hemorrhagic Fever 1997 CAB International 1 22
35. Gubler D. J., Saluzzo J. F., Dodet B., The emergence of dengue/dengue haemorrhagic fever as a global public health problem. Factors in the Emergence of Arbovirus Diseases 1997 Paris, France Elsevier 83 92
36. Gubler D. J., Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends in Microbiology 2002 10 2 100 103 2-s2.0-0036468861 10.1016/S0966-842X(01)02288-0 (Pubitemid 34119347)
37. Gubler D. J., Dengue/dengue haemorrhagic fever: history and current status. Novartis Foundation Symposium 2006 277 3 16. discussion 16-22, 71-13, 251-253 2-s2.0-33947506827
38. Halstead S. B., Dengue hemorrhagic fever: two infections and antibody dependent enhancement, a brief history and personal memoir. Revista Cubana de Medicina Tropical 2002 54 3 171 179 2-s2.0-33644877382
39. Halstead S. B., Dengue virus-mosquito interactions. Annual Review of Entomology 2008 53 273 291 2-s2.0-40349114934 10.1146/annurev.ento.53.103106. 093326 (Pubitemid 351341942)
40. Blanton R. E., Silva L. K., Morato V. G., Parrado A. R., Dias J. P., Melo P. R. S., Reis E. A. G., Goddard K. A. B., Nunes M. R. T., Rodrigues S. G., Vasconcelos P. F. C., Castro J. M., Reis M. G., Barreto M. L., Teixeira M. G., Genetic ancestry and income are associated with dengue hemorrhagic fever in a highly admixed population. European Journal of Human Genetics 2008 16 6 762 765 2-s2.0-44449118487 10.1038/ejhg.2008.4 (Pubitemid 351753374)
41. Sierra B. D. L. C., Kourí G., Guzmán M. G., Race: a risk factor for dengue hemorrhagic fever. Archives of Virology 2007 152 3 533 542 2-s2.0-33847655715 10.1007/s00705-006-0869-x (Pubitemid 46363592)
42. Guzman M. G., Kouri G., Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. Journal of Clinical Virology 2003 27 1 1 13 2-s2.0-0037408183 10.1016/S1386-6532(03)00010-6 (Pubitemid 36513584)
43. Singh N., Kiedrzynski T., Lepers C., Benyon E. K., Dengue in the Pacific-an update of the current situation. Pacific Health Dialog 2005 12 2 111 119 2-s2.0-39549113007
44. Wilder-Smith A., Gubler D. J., Geographic expansion of dengue: the impact of international travel. Medical Clinics of North America 2008 92 6 1377 1390 2-s2.0-55049084757 10.1016/j.mcna.2008.07.002
45. Franco C., Hynes N. A., Bouri N., Henderson D. A., The dengue threat to the United States. Biosecurity and Bioterrorism 2010 8 3 273 276 2-s2.0-77956515986 10.1089/bsp.2010.0032
46. Gould E. A., Gallian P., De Lamballerie X., Charrel R. N., First cases of autochthonous dengue fever and chikungunya fever in France: from bad dream to reality! Clinical Microbiology and Infection 2010 16 12 1702 1704 2-s2.0-78349249358 10.1111/j.1469-0691.2010.03386.x
47. Kurolt I. C., Betica-Radic L., Dakovic-Rode O., Franco L., Zelena H., Tenorio A., Markotic A., Molecular characterization of dengue virus 1 from autochthonous dengue fever cases in Croatia. Clinical Microbiology and Infection 2013 19 3 163 165
48. Guzman M. G., Kouri G., Dengue haemorrhagic fever integral hypothesis: confirming observations, 1987-2007. Transactions of the Royal Society of Tropical Medicine and Hygiene 2008 102 6 522 523 2-s2.0-43149116074 10.1016/j.trstmh.2008.03.001
49. Guzman M. G., Vazquez S., Martinez E., Alvarez M., Rodriguez R., Kouri G., De Los Reyes J., Acevedo F., Dengue in Nicaragua, 1994: reintroduction of serotype 3 in the Americas. Boletin de la Oficina Sanitaria Panamericana 1996 121 2 102 110 2-s2.0-0029663155
50. Guzmán M. G., Rosario D., Muné M., Alvarez M., Rodríguez R., Kourí G., Genetic relatedness of the dengue 3 virus isolated in the outbreak of dengue hemorrhagic fever in Nicaragua, 1994. Revista Cubana de Medicina Tropical 1996 48 2 114 117 2-s2.0-0030310556
51. Rico-Hesse R., Microevolution and virulence of dengue viruses. Advances in Virus Research 2003 59 315 341 2-s2.0-1542676372 10.1016/S0065-3527(03)59009- 1 (Pubitemid 137639369)
52. Teixeira M. G., Costa M. C. N., Coelho G., Barreto M. L., Recent shift in age pattern of dengue hemorrhagic fever, Brazil. Emerging Infectious Diseases 2008 14 10 1663 2-s2.0-54249143502 10.3201/eid1410.071164
53. Cavalcanti L. P., Vilar D., Souza-Santos R., Teixeira M. G., Change in age pattern of persons with dengue, Northeastern Brazil. Emerging Infectious Diseases 2011 17 1 132 134 2-s2.0-78650970534 10.3201/eid1701.100321
54. Benedict M. Q., Levine R. S., Hawley W. A., Lounibos L. P., Spread of the tiger: global risk of invasion by the mosquito Aedes albopictus. Vector-Borne and Zoonotic Diseases 2007 7 1 76 85 2-s2.0-34247262629 10.1089/vbz.2006.0562 (Pubitemid 46626693)
55. Charrel R. N., De Lamballerie X., Raoult D., Chikungunya outbreaks-the globalization of vectorborne diseases. The New England Journal of Medicine 2007 356 8 769 771 2-s2.0-33847115825 10.1056/NEJMp078013 (Pubitemid 46294608)
56. Sousa C., Clairouin M., Seixas G., Viveiros B., Novo M., Silva A., Escoval M., Economopoulou A., Ongoing outbreak of dengue type 1 in the Autonomous Region of Madeira, Portugal: preliminary report. Eurosurveillance 2012 17 49, article 3
57. Caminade C., Medlock J. M., Ducheyne E., McIntyre K. M., Leach S., Baylis M., Morse A. P., Suitability of European climate for the Asian tiger mosquito Aedes albopictus: recent trends and future scenarios. Journal of the Royal Society Interface 2012 9 75 2708 2717 10.1098/rsif.2012.0138
58. Wright W. F., Pritt B. S., Update: the diagnosis and management of dengue virus infection in North America. Diagnostic Microbiology and Infectious Disease 2012 2-s2.0-84859928730 10.1016/j.diagmicrobio.2012.03.021
59. Wu F., Liu Q., Lu L., Wang J., Song X., Ren D., Distribution of Aedes albopictus (Diptera: Culicidae) in northwestern China. Vector-Borne and Zoonotic Diseases 2011 11 8 1181 1186 2-s2.0-80051535527 10.1089/vbz.2010.0032
60. Guzmán M. G., Deciphering dengue: the Cuban experience. Science 2005 309 5740 1495 1497 2-s2.0-24644439199 10.1126/science.1115177 (Pubitemid 41266460)
61. Tan G. K., Alonso S., Pathogenesis and prevention of dengue virus infection: state-of-the-art. Current Opinion in Infectious Diseases 2009 22 3 302 308 2-s2.0-65549166750 10.1097/QCO.0b013e328329ae32
62. Mathew A., Rothman A. L., Understanding the contribution of cellular immunity to dengue disease pathogenesis. Immunological Reviews 2008 225 1 300 313 2-s2.0-52049102222 10.1111/j.1600-065X.2008.00678.x
63. Alvarez M., Rodriguez-Roche R., Bernardo L., Vázquez S., Morier L., Gonzalez D., Castro O., Kouri G., Halstead S. B., Guzman M. G., Dengue hemorrhagic fever caused by sequential dengue 1-3 virus infections over a long time interval: Havana epidemic, 2001-2002. The American Journal of Tropical Medicine and Hygiene 2006 75 6 1113 1117 2-s2.0-33747310786 (Pubitemid 351627493)
64. Guzmán M. G., Kouri G., Valdes L., Bravo J., Alvarez M., Vazques S., Delgado I., Halstead S. B., Epidemiologic studies on dengue in Santiago de Cuba, 1997. American Journal of Epidemiology 2000 152 9 793 799 2-s2.0-0034331203 10.1093/aje/152.9.793
65. Guzman M. G., Alvarez M., Rodriguez R., Rosario D., Vazquez S., Valdes L., Cabrera M. V., Kouri G., Fatal dengue hemorrhagic fever in Cuba. International Journal of Infectious Diseases 1997 3 3 130 135
66. Guzman M. G., Kouri G. P., Bravo J., Soler M., Vazquez S., Morier L., Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. The American Journal of Tropical Medicine and Hygiene 1990 42 2 179 184 2-s2.0-0025309681 (Pubitemid 20093452)
67. Bravo J. R., Guzmán M. G., Kouri G. P., Why dengue haemorrhagic fever in Cuba? I. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS). Transactions of the Royal Society of Tropical Medicine and Hygiene 1987 81 5 816 820 2-s2.0-0023465065
68. Valdés L., Guzmán M. G., Kourí G., Delgado J., Carbonell I., Cabrera M. V., Rosario D., Vázquez S., The epidemiology of dengue and dengue hemorrhagic fever in Santiago de Cuba, 1997. Revista Panamericana de Salud Publica 1999 6 1 16 25 2-s2.0-0032838512 (Pubitemid 29364519)
69. Sangkawibha N., Rojanasuphot S., Ahandrik S., Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. American Journal of Epidemiology 1984 120 5 653 669 2-s2.0-0021702322 (Pubitemid 15210730)
70. Halstead S. B., Nimmannitya S., Margiotta M. R., Dengue d chikungunya virus infection in man in Thailand, 1962-1964. II. Observations on disease in outpatients. The American Journal of Tropical Medicine and Hygiene 1969 18 6 972 983 2-s2.0-0014602625
71. Halstead S. B., The pathogenesis of dengue. Molecular epidemiology in infectious disease. American Journal of Epidemiology 1981 114 5 632 648 2-s2.0-0019638763 (Pubitemid 12241737)
72. Morens D. M., Antibody-dependent enhancement of infection and the pathogenesis of viral disease. Clinical Infectious Diseases 1994 19 3 500 512 2-s2.0-0028070971 (Pubitemid 24286955)
73. Mady B. J., Erbe D. V., Kurane I., Fanger M. W., Ennis F. A., Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc γ receptors. Journal of Immunology 1991 147 9 3139 3144 2-s2.0-0025947148
74. Kurane I., Mady B. J., Ennis F. A., Antibody-dependent enhancement of dengue virus infection. Reviews in Medical Virology 1991 1 4 211 221 2-s2.0-0000027866
75. Halstead S., Antibody-Dependent Enhancement of Infection: a mechanism for Indirect Virus Entry into Cells. Cellular Receptors for Animal Viruses 1994 Cold Spring Harbor, NY, USA Harbor Laboraty Press
76. Sabin A. B., Walter Schlesinger R., Production of immunity to dengue with virus modified by propagation in mice1. Science 1945 101 2634 640 642 2-s2.0-0000003107
77. Chareonsirisuthigul T., Kalayanarooj S., Ubol S., Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. Journal of General Virology 2007 88 2 365 375 2-s2.0-33846805819 10.1099/vir.0.82537-0 (Pubitemid 46210873)
78. Ubol S., Chareonsirisuthigul T., Kasisith J., Klungthong C., Clinical isolates of dengue virus with distinctive susceptibility to nitric oxide radical induce differential gene responses in THP-1 cells. Virology 2008 376 2 290 296 2-s2.0-44649150541 10.1016/j.virol.2008.03.030
79. Cologna R., Armstrong P. M., Rico-Hesse R., Selection for virulent dengue viruses occurs in humans and mosquitoes. Journal of Virology 2005 79 2 853 859 2-s2.0-11144246888 10.1128/JVI.79.2.853-859.2005 (Pubitemid 40053868)
80. Guzman M. G., Deubel V., Pelegrino J. L., Rosario D., Marrero M., Sariol C., Kouri G., Partial nucleotide and amino acid sequences of the envelope and the envelope/nonstructural protein-1 gene junction of four dengue-2 virus strains isolated during the 1981 Cuban epidemic. The American Journal of Tropical Medicine and Hygiene 1995 52 3 241 246 2-s2.0-0028902627
81. Kochel T. J., Watts D. M., Halstead S. B., Hayes C. G., Espinoza A., Felices V., Caceda R., Bautista C. T., Montoya Y., Douglas S., Russell K. L., Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever. The Lancet 2002 360 9329 310 312 2-s2.0-0037183318 10.1016/S0140-6736(02)09522-3 (Pubitemid 34874726)
82. Watts D. M., Porter K. R., Putvatana P., Vasquez B., Calampa C., Hayes C. G., Halstead S. B., Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever. The Lancet 1999 354 9188 1431 1434 2-s2.0-0033598597 10.1016/S0140-6736(99)04015-5 (Pubitemid 29494755)
83. Rico-Hesse R., Harrison L. M., Salas R. A., Tovar D., Nisalak A., Ramos C., Boshell J., De Mesa M. T. R., Nogueira R. M. R., Rosa A. T. D., Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 1997 230 2 244 251 2-s2.0-0345093502 10.1006/viro.1997.8504 (Pubitemid 27211855)
84. Leitmeyer K. C., Vaughn D. W., Watts D. M., Salas R., De Chacon I. V., Ramos C., Rico-Hesse R., Dengue virus structural differences that correlate with pathogenesis. Journal of Virology 1999 73 6 4738 4747 2-s2.0-0033052643 (Pubitemid 29246733)
85. González D., Castro O. E., Kourí G., Perez J., Martinez E., Vazquez S., Rosario D., Cancio R., Guzman M. G., Classical dengue hemorrhagic fever resulting from two dengue infections spaced 20 years or more apart: Havana, Dengue 3 epidemic, 2001-2002. International Journal of Infectious Diseases 2005 9 5 280 285 2-s2.0-23944471652 10.1016/j.ijid.2004.07.012 (Pubitemid 41196872)
86. Limonta D., González D., Capó V., Torres G., Pérez A. B., Rosario D., Roche-Rodriguez R., Alvarez M., Guzmán M. G., Fatal severe dengue and cell death in sickle cell disease during the 2001-2002 Havana dengue epidemic. International Journal of Infectious Diseases 2009 13 2 e77 e78 2-s2.0-60849094044 10.1016/j.ijid.2008.06.028
87. Lee M.-S., Hwang K.-P., Chen T.-C., Lu P.-L., Chen T.-P., Clinical characteristics of dengue and dengue hemorrhagic fever in a medical center of southern Taiwan during the 2002 epidemic. Journal of Microbiology, Immunology and Infection 2006 39 2 121 129 2-s2.0-33745432076 (Pubitemid 43954081)
88. Sierra B., Alegre R., Pérez A. B., García G., Sturn-Ramirez K., Obasanjo O., Aguirre E., Alvarez M., Rodriguez-Roche R., Valdés L., Kanki P., Guzmán M. G., HLA-A, -B, -C, and -DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: advantages of the Cuban population for HLA studies of dengue virus infection. Human Immunology 2007 68 6 531 540 2-s2.0-34248140776 10.1016/j.humimm.2007.03.001 (Pubitemid 46726862)
89. LaFleur C., Granados J., Vargas-Alarcon G., Ruíz-Morales J., Villarreal-Garza C., Higuera L., Hernández-Pacheco G., Cutiño-Moguel T., Rangel H., Figueroa R., Acosta M., Lazcano E., Ramos C., HLA-DR antigen frequencies in Mexican patients with dengue virus infection: HLA-DR4 as a possible genetic resistance factor for dengue hemorrhagic fever. Human Immunology 2002 63 11 1039 1044 2-s2.0-0036830279 10.1016/S0198-8859(02) 00682-1 (Pubitemid 35231688)
90. Stephens H. A. F., Klaythong R., Sirikong M., Vaughn D. W., Green S., Kalayanarooj S., Endy T. P., Libraty D. H., Nisalak A., Innis B. L., Rothman A. L., Ennis F. A., Chandanayingyong D., HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens 2002 60 4 309 318 2-s2.0-0036818735 10.1034/j.1399-0039.2002.600405.x (Pubitemid 36020803)
91. Paradoa Pérez M. L., Trujillo Y., Basanta P., Association of dengue hemorrhagic fever with the HLA system. Haematologia 1987 20 2 83 87 2-s2.0-0023079967
92. Chaturvedi U. C., Nagar R., Shrivastava R., Dengue and dengue haemorrhagic fever: implications of host genetics. FEMS Immunology and Medical Microbiology 2006 47 2 155 166 2-s2.0-33645472158 10.1111/j.1574-695X.2006. 00058.x (Pubitemid 43881735)
93. García G., Sierra B., Pérez A. B., Aguirre E., Rosado I., Gonzalez N., Izquierdo A., Pupo M., Ruiz D., Díaz D., Sánchez L., Marcheco B., Hirayama K., Guzmán M. G., Asymptomatic dengue infection in a cuban population confirms the protective role of the RR variant of the Fc γ RIIa polymorphism. The American Journal of Tropical Medicine and Hygiene 2010 82 6 1153 1156 2-s2.0-77953749447 10.4269/ajtmh.2010.09-0353
94. Mongkolsapaya J., Duangchinda T., Dejnirattisai W., Vasanawathana S., Avirutnan P., Jairungsri A., Khemnu N., Tangthawornchaikul N., Chotiyarnwong P., Sae-Jang K., Koch M., Jones Y., McMichael A., Xu X., Malasit P., Screaton G., T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal? Journal of Immunology 2006 176 6 3821 3829 2-s2.0-33644838912 (Pubitemid 43364031)
95. Clyde K., Kyle J. L., Harris E., Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. Journal of Virology 2006 80 23 11418 11431 2-s2.0-33751254102 10.1128/JVI.01257-06 (Pubitemid 44788858)
96. Sierra B., Perez A. B., Vogt K., Garcia G., Schmolke K., Aguirre E., Alvarez M., Kern F., Kourí G., Volk H.-D., Guzman M. G., Secondary heterologous dengue infection risk: disequilibrium between immune regulation and inflammation? Cellular Immunology 2010 262 2 134 140 2-s2.0-77950867164 10.1016/j.cellimm.2010.02.005
97. Whitehorn J., Simmons C. P., The pathogenesis of dengue. Vaccine 2011 29 42 7221 7228 2-s2.0-80052392189 10.1016/j.vaccine.2011.07.022
98. Avirutnan P., Punyadee N., Noisakran S., Komoltri C., Thiemmeca S., Auethavornanan K., Jairungsri A., Kanlaya R., Tangthawornchaikul N., Puttikhunt C., Pattanakitsakul S.-N., Yenchitsomanus P.-T., Mongkolsapaya J., Kasinrerk W., Sittisombut N., Husmann M., Blettner M., Vasanawathana S., Bhakdi S., Malasit P., Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. Journal of Infectious Diseases 2006 193 8 1078 1088 2-s2.0-33645798035 10.1086/500949
99. Lin C.-F., Wan S.-W., Chen M.-C., Lin S.-C., Cheng C.-C., Chiu S.-C., Hsiao Y.-L., Lei H.-Y., Liu H.-S., Yeh T.-M., Lin Y.-S., Liver injury caused by antibodies against dengue virus nonstructural protein 1 in a murine model. Laboratory Investigation 2008 88 10 1079 1089 2-s2.0-52649172616 10.1038/labinvest.2008.70
100. Cheng H.-J., Lin C.-F., Lei H.-Y., Liu H.-S., Yeh T.-M., Luo Y.-H., Lin Y.-S., Proteomic analysis of endothelial cell autoantigens recognized by anti-dengue virus nonstructural protein 1 antibodies. Experimental Biology and Medicine 2009 234 1 63 73 2-s2.0-60549094971 10.3181/0805-RM-147
101. Lin C.-F., Wan S.-W., Cheng H.-J., Lei H.-Y., Lin Y.-S., Autoimmune pathogenesis in dengue virus infection. Viral Immunology 2006 19 2 127 132 2-s2.0-33745882654 10.1089/vim.2006.19.127 (Pubitemid 44050311)
102. Brown M. G., Huang Y. Y., Marshall J. S., King C. A., Hoskin D. W., Anderson R., Dramatic caspase-dependent apoptosis in antibody-enhanced dengue virus infection of human mast cells. Journal of Leukocyte Biology 2009 85 1 71 80 2-s2.0-58149250278 10.1189/jlb.0308167
103. Brown M. G., King C. A., Sherren C., Marshall J. S., Anderson R., A dominant role for Fc γ RII in antibody-enhanced dengue virus infection of human mast cells and associated CCL5 release. Journal of Leukocyte Biology 2006 80 6 1242 1250 2-s2.0-33845426315 10.1189/jlb.0805441 (Pubitemid 44904963)
104. Falconar A. K. I., The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis. Archives of Virology 1997 142 5 897 916 2-s2.0-0031020410 10.1007/s007050050127 (Pubitemid 27218413)
105. Tam D. T., Ngoc T. V., Tien N. T., Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial. Clinical Infectious Diseases 2012 55 9 1216 1224 10.1093/cid/cis655
106. Lin S.-W., Chuang Y.-C., Lin Y.-S., Lei H.-Y., Liu H.-S., Yeh T.-M., Dengue virus nonstructural protein NS1 binds to prothrombin/thrombin and inhibits prothrombin activation. Journal of Infection 2012 64 3 325 334 2-s2.0-84856605644 10.1016/j.jinf.2011.11.023
107. Halstead S. B., Dengue vascular permeability syndrome: what, no T cells? Clinical Infectious Diseases 2013 56 6 900 901 10.1093/cid/cis1047
108. Libraty D. H., Young P. R., Pickering D., Endy T. P., Kalayanarooj S., Green S., Vaughn D. W., Nisalak A., Ennis F. A., Rothman A. L., High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. Journal of Infectious Diseases 2002 186 8 1165 1168 2-s2.0-0037108657 10.1086/343813 (Pubitemid 35177121)
109. Duyen H. T. L., Ngoc T. V., Ha D. T., Hang V. T. T., Kieu N. T. T., Young P. R., Farrar J. J., Simmons C. P., Wolbers M., Wills B. A., Kinetics of plasma viremia and soluble nonstructural protein 1 concentrations in dengue: differential effects according to serotype and immune status. Journal of Infectious Diseases 2011 203 9 1292 1300 2-s2.0-79954627419 10.1093/infdis/ jir014
110. Tricou V., Minh N. N., Farrar J., Tran H. T., Simmons C. P., Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengue. PLoS Neglected Tropical Diseases 2011 5 9 2-s2.0-80053456982 10.1371/journal.pntd.0001309 e1309
111. de la Cruz-Hernandez S. I., Flores-Aguilar H., Gonzalez-Mateos S., Lopez-Martinez I., Alpuche-Aranda C., Ludert J. E., Del Angel R. M., Determination of viremia and concentration of circulating nonstructural protein 1 in patients infected with dengue virus in Mexico. The American Journal of Tropical Medicine and Hygiene 2013 88 3 446 454 10.4269/ajtmh.12-0023
112. Fox A., Hoa L. N. M., Simmons C. P., Wolbers M., Wertheim H. F. L., Khuong P. T., Ninh T. T. H., Lien T. T. M., Lien N. T., Trung N. V., Hien N. D., Farrar J., Horby P., Taylor W. R., van Kinh N., Immunological and viral determinants of dengue severity in hospitalized adults in Ha Noi, Viet Nam. PLoS Neglected Tropical Diseases 2011 5 3, article e967 2-s2.0-79953768536 10.1371/journal.pntd.0000967
113. Kouri G. P., Guzmán M. G., Bravo J. R., Why dengue haemorrhagic fever in Cuba? 2. An integral analysis. Transactions of the Royal Society of Tropical Medicine and Hygiene 1987 81 5 821 823 2-s2.0-0023465922
114. Kyle J. L., Harris E., Global spread and persistence of dengue. Annual Review of Microbiology 2008 62 71 92 2-s2.0-50849098592 10.1146/annurev.micro. 62.081307.163005
115. Mas Lago P., Dengue fever in Cuba in 1977: some laboratory aspects. PAHO Scientific Publication 1979 375 40 43
116. Mas Lago P., Palomera R., Jacobo M., Dengue: some epidemiologic aspects. Revista Cubana de Medicina Tropical 1983 22 6
117. Cantelar de Francisco N., Fernández A., Albert Molina L., Pérez Balbis E., Survey of dengue in Cuba. 1978-1979. Revista Cubana de Medicina Tropical 1981 33 1 72 78 2-s2.0-17144459218
118. Halstead S. B., Nimmannitya S., Cohen S. N., Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale Journal of Biology and Medicine 1970 42 5 311 328 2-s2.0-0014775305
119. Guzmán M. G., Kouri G., Bravo J., Soler M., Martínez E., Sequential infection as risk factor for dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) during the 1981 dengue hemorrhagic Cuban epidemic. Memorias do Instituto Oswaldo Cruz 1991 86 3 367 2-s2.0-0026192133
120. Kourí G., Guzmán M. G., Valdés L., Carbonel I., Del Rosario D., Vazquez S., Laferté J., Delgado J., Cabrera M. V., Reemergence of dengue in Cuba: a 1997 epidemic in Santiago de Cuba. Emerging Infectious Diseases 1998 4 1 89 92 2-s2.0-0031874204 (Pubitemid 28347419)
121. Guzmán M. G., Kourí G., Valdés L., Bravo J., Vázquez S., Halstead S. B., Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks. Revista Panamericana de Salud Publica 2002 11 4 223 227 2-s2.0-0036107484 (Pubitemid 34555771)
122. Peláez O., Guzmán M. G., Kouri G., Dengue 3 epidemic, Havana, 2001. Emerging Infectious Diseases 2004 10 4 719 722 10.3201/eid1004.030271 (Pubitemid 38420309)
123. Álvarez M., Pavón-Oro A., Vázquez S., Morier L., Álvarez Á. M., Guzmán M. G., Viral infection sequences related to dengue fever in dengue 3 epidemics occurred in the City of Havana, 2001-2002. Revista Cubana de Medicina Tropical 2008 60 1 18 23 2-s2.0-47249165732
124. Alvarez M., Pavon-Oro A., Rodriguez-Roche R., Bernardo L., Morier L., Sanchez L., Alvarez A. M., Guzmán M. G., Neutralizing antibody response variation against dengue 3 strains. Journal of Medical Virology 2008 80 10 1783 1789 2-s2.0-50849091313 10.1002/jmv.21234
125. Rodriguez-Roche R., Alvarez M., Holmes E. C., Bernardo L., Kouri G., Gould E. A., Halstead S., Guzman M. G., Dengue virus type 3, Cuba, 2000-2002. Emerging Infectious Diseases 2005 11 5 773 774 2-s2.0-17844378220 (Pubitemid 40586412)
126. Rodriguez-Roche R., Alvarez M., Gritsun T., Rosario D., Halstead S., Kouri G., Gould E. A., Guzman M. G., Dengue virus type 2 in Cuba, 1997: conservation of E gene sequence in isolates obtained at different times during the epidemic. Archives of Virology 2005 150 3 415 425 2-s2.0-15244353393 10.1007/s00705-004-0445-1 (Pubitemid 40383677)
127. Sabin A. B., Research on dengue during World War II. The American Journal of Tropical Medicine and Hygiene 1952 1 1 30 50 2-s2.0-76949113583
128. Guzman M. G., Alvarez M., Rodriguez-Roche R., Bernardo L., Montes T., Vazquez S., Morier L., Alvarez A., Gould E. A., Kourí G., Halstead S. B., Neutralizing antibodies after infection with dengue 1 virus. Emerging Infectious Diseases 2007 13 2 282 286 2-s2.0-33846659386 (Pubitemid 46193173)
129. Guzmán M. G., Kourí G., Halstead S. B., Do escape mutants explain rapid increases in dengue case-fatality rates within epidemics? The Lancet 2000 355 9218 1902 1903 2-s2.0-0034720649 (Pubitemid 30311889)
130. Rodriguez-Roche R., Alvarez M., Gritsun T., Halstead S., Kouri G., Gould E. A., Guzman M. G., Virus evolution during a severe dengue epidemic in Cuba, 1997. Virology 2005 334 2 154 159 2-s2.0-15244348026 10.1016/j.virol.2005.01.037 (Pubitemid 40386950)
131. Mongkolsapaya J., Dejnirattisai W., Xu X.-N., Vasanawathana S., Tangthawornchaikul N., Chairunsri A., Sawasdivorn S., Duangchinda T., Dong T., Rowland-Jones S., Yenchitsomanus P.-T., McMichael A., Malasit P., Screaton G., Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nature Medicine 2003 9 7 921 927 2-s2.0-0038379214 10.1038/nm887 (Pubitemid 36889936)
132. Bennett S. N., Holmes E. C., Chirivella M., Rodriguez D. M., Beltran M., Vorndam V., Gubler D. J., McMillan W. O., Selection-driven evolution of emergent dengue virus. Molecular Biology and Evolution 2003 20 10 1650 1658 2-s2.0-1642379871 10.1093/molbev/msg182 (Pubitemid 41070827)
133. Klungthong C., Zhang C., Mammen M. P. Jr., Ubol S., Holmes E. C., The molecular epidemiology of dengue virus serotype 4 in Bangkok, Thailand. Virology 2004 329 1 168 179 2-s2.0-5144226152 10.1016/j.virol.2004.08.003 (Pubitemid 39346038)
134. Chen H.-L., Lin S.-R., Liu H.-F., King C.-C., Hsieh S.-C., Wang W.-K., Evolution of dengue virus type 2 during two consecutive outbreaks with an increase in severity in Southern Taiwan in 2001-2002. The American Journal of Tropical Medicine and Hygiene 2008 79 4 495 504 2-s2.0-53749083485
135. Tang Y., Rodpradit P., Chinnawirotpisan P., Mammen M. P. Jr., Li T., Lynch J. A., Putnak R., Zhang C., Comparative analysis of full-length genomic sequences of 10 dengue serotype 1 viruses associated with different genotypes, epidemics, and disease severity isolated in Thailand over 22 years. The American Journal of Tropical Medicine and Hygiene 2010 83 5 1156 1165 2-s2.0-79952045479 10.4269/ajtmh.2010.10-0052
136. Zhao R., Chinnawirotpisan P., Klungthong C., Zhang C., Putnak R., Evidence for inter- and intra-genotypic variations in dengue serotype 4 viruses representing predominant and non-predominant genotypes co-circulating in Thailand from 1977 to 2001. Virus Genes 2010 41 1 5 13 2-s2.0-77953871618 10.1007/s11262-010-0473-8
137. Rico-Hesse R., Dengue virus evolution and virulence models. Clinical Infectious Diseases 2007 44 11 1462 1466 2-s2.0-34249054978 10.1086/517587 (Pubitemid 46801591)
138. Steel A., Gubler D. J., Bennett S. N., Natural attenuation of dengue virus type-2 after a series of island outbreaks: a retrospective phylogenetic study of events in the South Pacific three decades ago. Virology 2010 405 2 505 512 2-s2.0-77955714309 10.1016/j.virol.2010.05.033
139. Rodriguez-Roche R., Villegas E., Cook S., Poh Kim P. A. W., Hinojosa Y., Rosario D., Villalobos I., Bendezu H., Hibberd M. L., Guzman M. G., Population structure of the dengue viruses, Aragua, Venezuela, 2006-2007. Insights into dengue evolution under hyperendemic transmission. Infection, Genetics and Evolution 2012 12 2 332 344 2-s2.0-84857640632 10.1016/j.meegid.2011.12.005
140. Chambers T. J., McCourt D. W., Rice C. M., Yellow fever virus proteins NS2A, NS2B, and NS4B: identification and partial N-terminal amino acid sequence analysis. Virology 1989 169 1 100 109 2-s2.0-0024590191 (Pubitemid 19080152)
141. MacKenzie J. M., Khromykh A. A., Jones M. K., Westaway E. G., Subcellular localization and some biochemical properties of the flavivirus Kunjin nonstructural proteins NS2A and NS4A. Virology 1998 245 2 203 215 2-s2.0-0032486487 10.1006/viro.1998.9156 (Pubitemid 28394183)
142. Wen J. L., Hua B. C., Xiang J. W., Huang H., Khromykh A. A., Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription. Journal of Virology 2004 78 22 12225 12235 2-s2.0-7644234588 10.1128/JVI.78.22.12225-12235.2004 (Pubitemid 39458742)
143. Liu W. J., Wang X. J., Clark D. C., Lobigs M., Hall R. A., Khromykh A. A., A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice. Journal of Virology 2006 80 5 2396 2404 2-s2.0-33144482922 10.1128/JVI.80.5.2396-2404.2006 (Pubitemid 43271545)
144. Muñoz-Jordán J. L., Sánchez-Burgos G. G., Laurent-Rolle M., García-Sastre A., Inhibition of interferon signaling by dengue virus. Proceedings of the National Academy of Sciences of the United States of America 2003 100 2 14333 14338 2-s2.0-0344630221 10.1073/pnas. 2335168100 (Pubitemid 37499237)
145. Liu W. J., Wang X. J., Mokhonov V. V., Shi P.-Y., Randall R., Khromykh A. A., Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins. Journal of Virology 2005 79 3 1934 1942 2-s2.0-13744254078 10.1128/JVI.79.3.1934-1942.2005 (Pubitemid 40459140)
146. Kümmerer B. M., Rice C. M., Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles. Journal of Virology 2002 76 10 4773 4784 2-s2.0-0036232747 10.1128/JVI.76.10. 4773-4784.2002 (Pubitemid 34441683)
147. Liu W. J., Chen H. B., Khromykh A. A., Molecular and functional analyses of Kunjin virus infectious cDNA clones demonstrate the essential roles for NS2A in virus assembly and for a nonconservative residue in NS3 in RNA replication. Journal of Virology 2003 77 14 7804 7813 2-s2.0-0038421087 10.1128/JVI.77.14. 7804-7813.2003 (Pubitemid 36792777)
148. Leung J. Y., Pijlman G. P., Kondratieva N., Hyde J., Mackenzie J. M., Khromykh A. A., Role of nonstructural protein NS2A in flavivirus assembly. Journal of Virology 2008 82 10 4731 4741 2-s2.0-43249124059 10.1128/JVI.00002-08 (Pubitemid 351657035)
149. McElroy K. L., Tsetsarkin K. A., Vanlandingham D. L., Higgs S., Manipulation of the yellow fever virus non-structural genes 2A and 4B and the 3′ non-coding region to evaluate genetic determinants of viral dissemination from the Aedes aegypti midgut. The American Journal of Tropical Medicine and Hygiene 2006 75 6 1158 1164 2-s2.0-39049185910 (Pubitemid 351627501)
150. Hanley K. A., Manlucu L. R., Gilmore L. E., Blaney J. E. Jr., Hanson C. T., Murphy B. R., Whitehead S. S., A trade-off in replication in mosquito versus mammalian systems conferred by a point mutation in the NS4B protein of dengue virus type 4. Virology 2003 312 1 222 232 2-s2.0-0043169616 10.1016/S0042- 6822(03)00197-1 (Pubitemid 36918474)
151. Kelly E. P., Puri B., Sun W., Falgout B., Identification of mutations in a candidate dengue 4 vaccine strain 341750 PDK20 and construction of a full-length cDNA clone of the PDK20 vaccine candidate. Vaccine 2010 28 17 3030 3037 2-s2.0-77949653562 10.1016/j.vaccine.2009.10.084
152. Tajima S., Takasaki T., Kurane I., Restoration of replication-defective dengue type 1 virus bearing mutations in the N-terminal cytoplasmic portion of NS4A by additional mutations in NS4B. Archives of Virology 2011 156 1 63 69 2-s2.0-78650785659 10.1007/s00705-010-0816-8
153. Grant D., Tan G. K., Qing M., Ng J. K. W., Yip A., Zou G., Xie X., Yuan Z., Schreiber J., Schul W., Shi P.-Y., Alonso S., A single amino acid in nonstructural protein NS4B Confers virulence to dengue virus in AG129 mice through enhancement of viral RNA synthesis. Journal of Virology 2011 85 15 7775 7787 2-s2.0-79960388759 10.1128/JVI.00665-11
154. Roche R. R., Alvarez M., Guzman M. G., Morier L., Kouri G., Comparison of rapid centrifugation assay with conventional tissue culture method for isolation of dengue 2 virus in C6/36-HT cells. Journal of Clinical Microbiology 2000 38 9 3508 3510 2-s2.0-0033835242
155. Wang W.-K., Lin S.-R., Lee C.-M., King C.-C., Chang S.-C., Dengue type 3 virus in plasma is a population of closely related genomes: quasispecies. Journal of Virology 2002 76 9 4662 4665 2-s2.0-0036229533 10.1128/JVI.76.9.4662- 4665.2002 (Pubitemid 34309604)
156. Aaskov J., Buzacott K., Thu H. M., Lowry K., Holmes E. C., Long-term transmission of defective RNA viruses in humans and Aedes mosquitoes. Science 2006 311 5758 236 238 2-s2.0-30844446303 10.1126/science.1115030 (Pubitemid 43108190)
157. OhAinle M., Balmaseda A., Macalalad A. R., Tellez Y., Zody M. C., Saborío S., Nuñez A., Lennon N. J., Birren B. W., Gordon A., Henn M. R., Harris E., Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity. Science Translational Medicine 2011 3 114 2-s2.0-84255168505 10.1126/scitranslmed. 3003084 114ra128
158. Foster J. E., Bennett S. N., Carrington C. V. F., Vaughan H., McMillan W. O., Phylogeography and molecular evolution of dengue 2 in the Caribbean basin, 1981-2000. Virology 2004 324 1 48 59 2-s2.0-2942564075 10.1016/j.virol.2004.03. 020 (Pubitemid 38737398)
159. Messer W. B., Vitarana U. T., Sivananthan K., Elvtigala J., Preethimala L. D., Ramesh R., Withana N., Gubler D. J., De Silva A. M., Epidemiology of dengue in Sri lanka before and after the emergence of epidemic dengue hemorrhagic fever. The American Journal of Tropical Medicine and Hygiene 2002 66 6 765 773 2-s2.0-0036592696 (Pubitemid 35001053)
160. Thu H. M., Lowry K., Jiang L., Hlaing T., Holmes E. C., Aaskov J., Lineage extinction and replacement in dengue type 1 virus populations are due to stochastic events rather than to natural selection. Virology 2005 336 2 163 172 2-s2.0-18844448460 10.1016/j.virol.2005.03.018 (Pubitemid 40693951)
161. Salda L. T. D., Parquet M. D. C., Matias R. R., Natividad F. F., Kobayashi N., Morita K., Molecular epidemiology of dengue 2 viruses in the Philippines: genotype shift and local evolution. The American Journal of Tropical Medicine and Hygiene 2005 73 4 796 802 2-s2.0-26844535011 (Pubitemid 41446732)
162. Vu T. T. H., Holmes E. C., Duong V., Nguyen T. Q., Tran T. H., Quail M., Churcher C., Parkhill J., Cardosa J., Farrar J., Wills B., Lennon N. J., Birren B. W., Buchy P., Henn M. R., Simmons C. P., Emergence of the Asian 1 genotype of dengue virus serotype 2 in viet nam: in vivo fitness advantage and lineage replacement in South-East Asia. PLoS Neglected Tropical Diseases 2010 4 7 e757 2-s2.0-77957897300 10.1371/journal.pntd.0000757
163. Holmes E. C., RNA virus genomics: a world of possibilities. Journal of Clinical Investigation 2009 119 9 2488 2495 2-s2.0-70349196002 10.1172/JCI38050
164. Limonta D., Capó V., Torres G., Pérez A. B., Guzmán M. G., Apoptosis in tissues from fatal dengue shock syndrome. Journal of Clinical Virology 2007 40 1 50 54 2-s2.0-34548126493 10.1016/j.jcv.2007.04.024 (Pubitemid 47302858)
165. Moya A., Holmes E. C., González-Candelas F., The population genetics and evolutionary epidemiology of RNA viruses. Nature Reviews Microbiology 2004 2 4 279 288 2-s2.0-2142753891 10.1038/nrmicro863 (Pubitemid 39490098)
166. Navas S., Martín J., Quiroga J. A., Castillo I., Carreño V., Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients. Journal of Virology 1998 72 2 1640 1646 2-s2.0-0031932434 (Pubitemid 28116955)
167. Miralles R., Moya A., Elena S. F., Effect of population patchiness and migration rates on the adaptation and divergence of vesicular stomatitis virus quasispecies populations. Journal of General Virology 1999 80 8 2051 2059 2-s2.0-0032812340 (Pubitemid 29389142)
168. Farci P., Shimoda A., Coiana A., Diaz G., Peddis G., Melpolder J. C., Strazzera A., Chien D. Y., Munoz S. J., Balestrieri A., Purcell R. H., Alter H. J., The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 2000 288 5464 339 344 2-s2.0-0034646996 10.1126/science.288.5464.339 (Pubitemid 30226196)
169. Holmes E. C., Patterns of intra- and interhost nonsynonymous variation reveal strong purifying selection in dengue virus. Journal of Virology 2003 77 20 11296 11298 2-s2.0-0141565071 10.1128/JVI.77.20.11296-11298.2003 (Pubitemid 37204321)
170. Lin S.-R., Hsieh S.-C., Yueh Y.-Y., Lin T.-H., Chao D.-Y., Chen W.-J., King C.-C., Wang W.-K., Study of sequence variation of dengue type 3 virus in naturally infected mosquitoes and human hosts: implications for transmission and evolution. Journal of Virology 2004 78 22 12717 12721 2-s2.0-7644242701 10.1128/JVI.78.22.12717-12721.2004 (Pubitemid 39458795)
171. Descloux E., Cao-Lormeau V.-M., Roche C., De Lamballerie X., Dengue 1 diversity and microevolution, French Polynesia 2001-2006: connection with epidemiology and clinics. PLoS Neglected Tropical Diseases 2009 3 8, article e493 2-s2.0-70449510163 10.1371/journal.pntd.0000493
172. Thai K. T. D., Henn M. R., Zody M. C., Tricou V., Nguyet N. M., Charlebois P., Lennon N. J., Green L., de Vries P. J., Hien T. T., Farrar J., van Doorn H. R., de Jong M. D., Birren B. W., Holmes E. C., Simmons C. P., High-resolution analysis of intrahost genetic diversity in dengue virus serotype 1 infection identifies mixed infections. Journal of Virology 2012 86 2 835 843 2-s2.0-84856846767 10.1128/JVI.05985-11
173. Parameswaran P., Charlebois P., Tellez Y., Genome-wide patterns of intrahuman dengue virus diversity reveal associations with viral phylogenetic clade and interhost diversity. Journal of Virology 2012 86 16 8546 8558 10.1128/JVI.00736-12
174. Costa R. L., Voloch C. M., Schrago C. G., Comparative evolutionary epidemiology of dengue virus serotypes. Infection, Genetics and Evolution 2012 12 2 309 314 2-s2.0-84857654294 10.1016/j.meegid.2011.12.011
175. Lourenço J., Recker M., Viral and epidemiological determinants of the invasion dynamics of Novel Dengue Genotypes. PLoS Neglected Tropical Diseases 2010 4 11, article e894 2-s2.0-78649772319 10.1371/journal.pntd.0000894
176. Wittke V., Robb T. E., Thu H. M., Nisalak A., Nimmannitya S., Kalayanrooj S., Vaughn D. W., Endy T. P., Holmes E. C., Aaskov J. G., Extinction and rapid emergence of strains of dengue 3 virus during an interepidemic period. Virology 2002 301 1 148 156 2-s2.0-0036395194 10.1006/viro.2002.1549 (Pubitemid 35168510)
177. Chevillon C., Failloux A.-B., Questions on viral population biology to complete dengue puzzle. Trends in Microbiology 2003 11 9 415 421 2-s2.0-0042825891 10.1016/S0966-842X(03)00206-3 (Pubitemid 37101480)
178. Lambrechts L., Fansiri T., Pongsiri A., Thaisomboonsuk B., Klungthong C., Richardson J. H., Ponlawat A., Jarman R. G., Scott T. W., Dengue-1 virus clade replacement in Thailand associated with enhanced mosquito transmission. Journal of Virology 2012 86 3 1853 1861 2-s2.0-84857073122 10.1128/JVI.06458-11
179. Bancroft W. H., Scott R. M., Brandt W. E., Dengue-2 vaccine: infection of Aedes aegypti mosquitoes by feeding on viremic recipients. The American Journal of Tropical Medicine and Hygiene 1982 31 6 1229 1231 2-s2.0-0020425953 (Pubitemid 13203880)
180. Miller B. R., Beaty B. J., Aitken T. H. G., Dengue-2 vaccine: oral infection, transmission, and lack of evidence for reversion in the mosquito, Aedes aegypti. The American Journal of Tropical Medicine and Hygiene 1982 31 6 1232 1237 2-s2.0-0020425954 (Pubitemid 13203881)
181. Gubler D. J., Nalim S., Tan R., Variation in susceptibility to oral infection with dengue viruses among geographic strains of Aedes aegypti. The American Journal of Tropical Medicine and Hygiene 1979 28 6 1045 1052 2-s2.0-0018731987 (Pubitemid 10215848)
182. Armstrong P. M., Rico-Hesse R., Differential susceptibility of Aedes aegypti to infection by the American and Southeast Asian genotypes of dengue type 2 virus. Vector Borne Zoonotic Dis 2001 1 2 159 168 2-s2.0-0035384630
183. Soper F. L., Aedes aegypti and yellow fever. Bulletin of the World Health Organization 1967 36 4 521 527 2-s2.0-0014189894
184. Gubler D. J., Aedes aegypti and Aedes aegypti -borne disease control in the 1990s: top down or bottom up. Charles Franklin Craig Lecture. The American Journal of Tropical Medicine and Hygiene 1989 40 6 571 578 2-s2.0-0024687325
185. Ooi E.-E., Goh K.-T., Gubler D. J., Dengue prevention and 35 years of vector control in Singapore. Emerging Infectious Diseases 2006 12 6 887 893 2-s2.0-33744927949 (Pubitemid 43848408)
186. Guzman M. G., Pelaez O., Kouri G., Quintana I., Vazquez S., Penton M., Avila L. C., Final characterization of and lessons learned from the dengue 3 epidemic in Cuba, 2001-2002. Revista Panamericana de Salud Pública 2006 19 4 282 289
187. Bonet M., Spiegel J. M., Ibarra A. M., Kouri G., Pintre Lic A., Yassi A., An integrated ecosystem approach for sustainable prevention and control of dengue in Central Havana. International Journal of Occupational and Environmental Health 2007 13 2 188 194 2-s2.0-34250851659 (Pubitemid 46988471)
188. Bisset J. A., Rodríguez M. M., Ricardo Y., Ranson H., Pérez O., Moya M., Vázquez A., Temephos resistance and esterase activity in the mosquito Aedes aegypti in Havana, Cuba increased dramatically between 2006 and 2008. Medical and Veterinary Entomology 2011 25 3 233 239 2-s2.0-79955093140 10.1111/j.1365-2915.2011.00959.x
189. Maciel-de-Freitas R., Aguiar R., Bruno R. V., Why do we need alternative tools to control mosquito-borne diseases in Latin America? Memórias do Instituto Oswaldo Cruz 2012 107 6 828 829
190. Sá R. A., Santos N. D. D. L., Silva C. S. B. D., Napoleão T. H., Gomes F. S., Cavada B. S., Coelho L. C. B. B., Navarro D. M. D. A. F., Bieber L. W., Paiva P. M. G., Larvicidal activity of lectins from Myracrodruon urundeuva on Aedes aegypti. Comparative Biochemistry and Physiology Part C 2009 149 3 300 306 2-s2.0-60649083576 10.1016/j.cbpc.2008.08.004
191. Billingsley P. F., Foy B., Rasgon J. L., Mosquitocidal vaccines: a neglected addition to malaria and dengue control strategies. Trends in Parasitology 2008 24 9 396 400 2-s2.0-49449097038 10.1016/j.pt.2008.06.003
192. Bisset Lazcano J. A., Marquetti M. C., Garcia A., Vandelerberghe V., Leyva M., Van der Stuyft P., Rodriguez M. M., Infante E., Pupal surveillance of Aedes aegypti as a tool for control of the vector in a municipality with low density of La Habana City, Cuba. Revista Biomédica 2008 19 92 103
193. Tuyet Hanh T. T., Hill P. S., Kay B. H., Tran M. Q., Development of a framework for evaluating the sustainability of community-based dengue control projects. The American Journal of Tropical Medicine and Hygiene 2009 80 2 312 318 2-s2.0-59649113611
194. Vu S. N., Nguyen T. Y., Kay B. H., Marten G. G., Reid J. W., Eradication of Aedes aegypti from a village in Vietnam, using copepods and community participation. The American Journal of Tropical Medicine and Hygiene 1998 59 4 657 660 2-s2.0-0003449202 (Pubitemid 28480729)
195. Nam V. S., Yen N. T., Phong T. V., Ninh T. U., Mai L. Q., Lo L. V., Nghia L. T., Bektas A., Briscombe A., Aaskov J. G., Ryan P. A., Kay B. H., Elimination of dengue by community programs using Mesocyclops (copepoda) against Aedes aegypti in central Vietnam. The American Journal of Tropical Medicine and Hygiene 2005 72 1 67 73 2-s2.0-13844260603 (Pubitemid 41270310)
196. Kay B., Nam V. S., New strategy against Aedes aegypti in Vietnam. The Lancet 2005 365 9459 613 617 2-s2.0-13844275411 10.1016/S0140-6736(05)17913-6 (Pubitemid 40247920)
197. Sánchez L., Pérez D., Alfonso L., Castro M., Sánchez L. M., Van Der Stuyft P., Kourí G., A community education strategy to promote participation in dengue prevention in Cuba. Revista Panamericana de Salud Publica 2008 24 1 61 69 2-s2.0-51249109729
198. McMeniman C. J., Lane R. V., Cass B. N., Fong A. W. C., Sidhu M., Wang Y.-F., O'Neill S. L., Stable introduction of a life-shortening Wolbachia infection into the mosquito Aedes aegypti. Science 2009 323 5910 141 144 2-s2.0-58149264955 10.1126/science.1165326
199. Lu P., Bian G., Pan X., Xi Z., Wolbachia induces density-dependent inhibition to dengue virus in mosquito cells. PLOS Neglected Tropical Diseases 2012 6 7 e1754
200. Walker T., Johnson P. H., Moreira L. A., Iturbe-Ormaetxe I., Frentiu F. D., McMeniman C. J., Leong Y. S., Dong Y., Axford J., Kriesner P., Lloyd A. L., Ritchie S. A., O'Neill S. L., Hoffmann A. A., The wMel Wolbachia strain blocks dengue and invades caged Aedes aegypti populations. Nature 2011 476 7361 450 455 2-s2.0-80051511670 10.1038/nature10355
201. Bian G., Xu Y., Lu P., Xie Y., Xi Z., The endosymbiotic bacterium Wolbachia induces resistance to dengue virus in Aedes aegypti. PLoS Pathogens 2010 6 4 e1000833 2-s2.0-77953921196
202. Moreira L. A., Iturbe-Ormaetxe I., Jeffery J. A., Lu G., Pyke A. T., Hedges L. M., Rocha B. C., Hall-Mendelin S., Day A., Riegler M., Hugo L. E., Johnson K. N., Kay B. H., McGraw E. A., van den Hurk A. F., Ryan P. A., O'Neill S. L., A Wolbachia Symbiont in Aedes aegypti Limits Infection with Dengue, Chikungunya, and Plasmodium. Cell 2009 139 7 1268 1278 2-s2.0-72249105145 10.1016/j.cell.2009.11.042
203. Pan X., Zhou G., Wu J., Bian G., Lu P., Raikhel A. S., Xi Z., Wolbachia induces reactive oxygen species (ROS)-dependent activation of the Toll pathway to control dengue virus in the mosquito Aedes aegypti. Proceedings of the National Academy of Sciences of the United States of America 2012 109 1 E23 E31 2-s2.0-84855986938 10.1073/pnas.1116932108
204. Mousson L., Zouache K., Arias-Goeta C., Raquin V., Mavingui P., Failloux A. B., The native wolbachia symbionts limit transmission of dengue virus in Aedes albopictus. PLOS Neglected Tropical Diseases 2012 6 12 e1989
205. Cook P. E., McMeniman C. J., O'Neill S. L., Modifying insect population age structure to control vector-borne disease. Advances in Experimental Medicine and Biology 2008 627 126 140 2-s2.0-48249146612 10.1007/978-0-387-78225-6-11
206. Endersby N. M., Hoffmann A. A., White V. L., Ritchie S. A., Johnson P. H., Weeks A. R., Changes in the genetic structure of Aedes aegypti (Diptera: Culicidae) populations in Queensland, Australia, across two seasons: implications for potential mosquito releases. Journal of Medical Entomology 2011 48 5 999 1007 2-s2.0-80052719465 10.1603/ME10264
207. Endersby N. M., Hoffmann A. A., White V. L., Lowenstein S., Ritchie S., Johnson P. H., Rapley L. P., Ryan P. A., Nam V. S., Yen N. T., Kittiyapong P., Weeks A. R., Genetic structure of Aedes aegypti in Australia and Vietnam revealed by microsatellite and exon primed intron crossing markers suggests feasibility of local control options. Journal of Medical Entomology 2009 46 5 1074 1083 2-s2.0-70350519661 10.1603/033.046.0514
208. Jeffery J. A. L., Yen N. T., Nam V. S., Nghia L. T., Hoffmann A. A., Kay B. H., Ryan P. A., Characterizing the Aedes aegypti population in a Vietnamese village in preparation for a Wolbachia-based mosquito control strategy to eliminate dengue. PLoS Neglected Tropical Diseases 2009 3 11 2-s2.0-73449138363 10.1371/journal.pntd.0000552 e0000552
209. Yeap H. L., Mee P., Walker T., Weeks A. R., O'Neill S. L., Johnson P., Ritchie S. A., Richardson K. M., Doig C., Endersby N. M., Hoffmann A. A., Dynamics of the "popcorn" Wolbachia infection in outbred Aedes aegypti informs prospects for mosquito vector control. Genetics 2011 187 2 583 595 2-s2.0-79951537264 10.1534/genetics.110.122390
210. Macey R., Dengue fever breakthrough. Sydney Morning Herald, 2009, http://www.smh.com.au/news/specials/science/dengue-fever-breakthrough/2009/01/ 02/1230681699070.html
211. Endersby N. M., Hoffmann A. A., Effect of Wolbachia on insecticide susceptibility in lines of Aedes aegypti. Bulletin of Entomological Research 2012 1 9
212. Halstead S. B., Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Reviews of Infectious Diseases 1989 11 S830 839 2-s2.0-0024670486
213. Hombach J., Jane Cardosa M., Sabchareon A., Vaughn D. W., Barrett A. D. T., Scientific consultation on immunological correlates of protection induced by dengue vaccines. Report from a meeting held at the World Health Organization 17-18 November 2005. Vaccine 2007 25 21 4130 4139 2-s2.0-34247337264 10.1016/j.vaccine.2007.02.079 (Pubitemid 46635942)
214. Swaminathan S., Batra G., Khanna N., Dengue vaccines: state of the art. Expert Opinion on Therapeutic Patents 2010 20 6 819 835 2-s2.0-77952564834 10.1517/13543771003767476
215. Edelman R., Wasserman S. S., Bodison S. A., Putnak R. J., Eckels K. H., Tang D., Kanesa-Thasan N., Vaughn D. W., Innis B. L., Sun W., Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine. The American Journal of Tropical Medicine and Hygiene 2003 69 6 48 60 2-s2.0-1342310100
216. Simasathien S., Thomas S. J., Watanaveeradej V., Nisalak A., Barberousse C., Innis B. L., Sun W., Putnak J. R., Eckels K. H., Hutagalung Y., Gibbons R. V., Zhang C., De La Barrera R., Jarman R. G., Chawachalasai W., Mammen M. P. Jr., Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children. The American Journal of Tropical Medicine and Hygiene 2008 78 3 426 433 2-s2.0-42949164977 (Pubitemid 351845193)
217. Sun W., Cunningham D., Wasserman S. S., Perry J., Putnak J. R., Eckels K. H., Vaughn D. W., Thomas S. J., Kanesa-Thasan N., Innis B. L., Edelman R., Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults. Human Vaccines 2009 5 1 33 40 2-s2.0-63349098458 10.4161/hv.5.1.6348
218. Durbin A. P., Whitehead S. S., McArthur J., Perreault J. R., Blaney J. E. Jr., Thumar B., Murphy B. R., Karron R. A., rDEN4 σ 30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers. Journal of Infectious Diseases 2005 191 5 710 718 2-s2.0-13944278364 10.1086/427780 (Pubitemid 40271058)
219. Durbin A. P., McArthur J., Marron J. A., Blaney J. E. Jr., Thumar B., Wanionek K., Murphy B. R., Whitehead S. S., The live attenuated dengue serotype 1 vaccine rDEN1Δ30 is safe and highly immunogenic in healthy adult volunteers. Human Vaccines 2006 2 4 167 173 2-s2.0-33748847886 (Pubitemid 44422483)
220. Durbin A. P., McArthur J. H., Marron J. A., Blaney J. E., Thumar B., Wanionek K., Murphy B. R., Whitehead S. S., rDEN2/4Δ30(ME), a live attenuated chimeric dengue serotype 2 vaccine, is safe and highly immunogenic in healthy dengue-naïve adults. Human Vaccines 2006 2 6 255 260 2-s2.0-33845895530 (Pubitemid 46025657)
221. McArthur J. H., Durbin A. P., Marron J. A., Wanionek K. A., Thumar B., Pierro D. J., Schmidt A. C., Blaney J. E. Jr., Murphy B. R., Whitehead S. S., Phase I clinical evaluation of rDEN4Δ30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity. The American Journal of Tropical Medicine and Hygiene 2008 79 5 678 684 2-s2.0-55849093621
222. Blaney J. E. Jr., Sathe N. S., Goddard L., Hanson C. T., Romero T. A., Hanley K. A., Murphy B. R., Whitehead S. S., Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3′ untranslated region (3′ -UTR) or by exchange of the DENV-3 3′ -UTR with that of DENV-4. Vaccine 2008 26 6 817 828 2-s2.0-38349050191 10.1016/j.vaccine.2007.11. 082
223. Guzman M. G., Hermida L., Bernardo L., Ramirez R., Guillén G., Domain III of the envelope protein as a dengue vaccine target. Expert Review of Vaccines 2010 9 2 137 147 2-s2.0-77950350548 10.1586/erv.09.139
224. Guirakhoo F., Kitckener S., Morrison D., Forrat R., McCarthy K., Nichols R., Yoksan S., Duan X., Ermak T. H., Kanesa-Thasan N., Bedford P., Lang J., Quentin-Millet M.-J., Monath T. P., Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: phase I clinical trial for safety and immunogenicity-effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes. Human Vaccines 2006 2 2 60 67 2-s2.0-33745237160 (Pubitemid 43927159)
225. Guy B., Nougarede N., Begue S., Sanchez V., Souag N., Carre M., Chambonneau L., Morrisson D. N., Shaw D., Qiao M., Dumas R., Lang J., Forrat R., Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects. Vaccine 2008 26 45 5712 5721 2-s2.0-52949106847 10.1016/j.vaccine.2008.08.019
226. Guy B., Guirakhoo F., Barban V., Higgs S., Monath T. P., Lang J., Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses. Vaccine 2010 28 3 632 649 2-s2.0-71449111221 10.1016/j.vaccine.2009.09.098
227. Guy B., Saville M., Lang J., Development of Sanofi Pasteur tetravalent dengue vaccine. Human Vaccines 2010 6 9 696 705 2-s2.0-78649384507 10.4161.hv.6.9.12739
228. Sabchareon A., Wallace D., Sirivichayakul C., Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. The Lancet 2012 380 9853 1559 1567
229. Swaminathan S., Khanna N., Herring B., Mahalingam S., Dengue vaccine efficacy trial: does interference cause failure? The Lancet Infectious Diseases 2013 13 3 191 192
230. Guzman M. G., Alvarez A., Vazquez S., Alvarez M., Rosario D., Pelaez O., Cruz G., Rodriguez R., Pavon A., Gonzalez A., Morier L., Ruiz D., Kouri G., Halstead S. B., Epidemiological studies on dengue virus type 3 in Playa municipality, Havana, Cuba, 2001-2002. International Journal of Infectious Diseases 2012 16 3 e198 e203 2-s2.0-84857062148 10.1016/j.ijid.2011.09.026
231. Halstead S. B., Dengue vaccine development: a 75% solution? The Lancet 2012 380 9853 1535 1536
232. Wahala W. M. P. B., de Silva A. M., The human antibody response to dengue virus infection. Viruses 2011 3 12 2374 2395 2-s2.0-84255191089 10.3390/v3122374
233. Osorio J. E., Huang C. Y.-H., Kinney R. M., Stinchcomb D. T., Development of DENVax: a chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever. Vaccine 2011 29 42 7251 7260 2-s2.0-80052418874 10.1016/j.vaccine.2011.07.020
234. Osorio J. E., Brewoo J. N., Silengo S. J., Arguello J., Moldovan I. R., Tary-Lehmann M., Powell T. D., Livengood J. A., Kinney R. M., Huang C. Y.-H., Stinchcomb D. T., Efficacy of a tetravalent chimeric dengue vaccine (DENVax) in cynomolgus macaques. The American Journal of Tropical Medicine and Hygiene 2011 84 6 978 987 2-s2.0-79958710286 10.4269/ajtmh.2011.10-0592
235. Brewoo J. N., Kinney R. M., Powell T. D., Arguello J. J., Silengo S. J., Partidos C. D., Huang C. Y.-H., Stinchcomb D. T., Osorio J. E., Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice. Vaccine 2012 30 8 1513 1520 2-s2.0-84856568145 10.1016/j.vaccine.2011.11.072
236. Hermida L., Bernardo L., Martín J., Alvarez M., Prado I., López C., Sierra B. D. L. C., Martínez R., Rodríguez R., Zulueta A., Pérez A. B., Lazo L., Rosario D., Guillén G., Guzmán M. G., A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates. Vaccine 2006 24 16 3165 3171 2-s2.0-33645092906 10.1016/j.vaccine. 2006.01.036
237. Bernardo L., Izquierdo A., Alvarez M., Rosario D., Prado I., López C., Martínez R., Castro J., Santana E., Hermida L., Guillen G., Guzmán M. G., Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates. Antiviral Research 2008 80 2 194 199 2-s2.0-53449083630 10.1016/j.antiviral.2008.06.005
238. Izquierdo A., Bernardo L., Martin J., Santana E., Hermida L., Guillén G., Guzmán M. G., Serotype-specificity of recombinant fusion proteins containing domain III of dengue virus. Virus Research 2008 138 1-2 135 138 2-s2.0-55749098473 10.1016/j.virusres.2008.08.008
239. Etemad B., Batra G., Raut R., Dahiya S., Khanam S., Swaminathan S., Khanna N., An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes. The American Journal of Tropical Medicine and Hygiene 2008 79 3 353 363 2-s2.0-51949088329
240. Gao G., Wang Q., Dai Z., Calcedo R., Sun X., Li G., Wilson J. M., Adenovirus-based vaccines generate cytotoxic T lymphocytes to epitopes of NS1 from dengue virus that are present in all major serotypes. Human Gene Therapy 2008 19 9 927 936 2-s2.0-51849090000 10.1089/hum.2008.011
241. Brandler S., Lucas-Hourani M., Moris A., Frenkiel M.-P., Combredet C., Février M., Bedouelle H., Schwartz O., Desprès P., Tangy F., Pediatric measles vaccine expressing a dengue antigen induces durable serotype-specific neutralizing antibodies to dengue virus. PLoS Neglected Tropical Diseases 2007 1 3, article e96 2-s2.0-47749147699 10.1371/journal.pntd. 0000096 (Pubitemid 352024640)
242. Valdés I., Bernardo L., Gil L., Pavón A., Lazo L., López C., Romero Y., Menendez I., Falcón V., Betancourt L., Martín J., Chinea G., Silva R., Guzmán M. G., Guillén G., Hermida L., A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in mice. Virology 2009 394 2 249 258 2-s2.0-70449527814 10.1016/j.virol.2009.08.029
243. Marcos E., Gil L., Lazo L., Purified and highly aggregated chimeric protein DIIIC-2 induces a functional immune response in mice against dengue 2 virus. Archives of Virology 2013 158 1 225 230
244. Lazo L., Gil L., Lopez C., Valdes I., Blanco A., Pavon A., Romero Y., Guzman M. G., Guillen G., Hermida L., A vaccine formulation consisting of nucleocapsid-like particles from Dengue-2 and the fusion protein P64k-domain III from Dengue-1 induces a protective immune response against the homologous serotypes in mice. Acta Tropica 2012 124 2 107 112 10.1016/j.actatropica.2012. 06.006
245. Gil L., Bernardo L., Pavon A., Recombinant nucleocapsid-like particles from dengue-2 induce functional serotype-specific cell-mediated immunity in mice. Journal of General Virology 2012 93, part 6 1204 1214
246. Chiang C.-Y., Liu S.-J., Tsai J.-P., Li Y.-S., Chen M.-Y., Liu H.-H., Chong P., Leng C.-H., Chen H.-W., A novel single-dose dengue subunit vaccine induces memory immune responses. PLoS ONE 2011 6 8 2-s2.0-79961081811 10.1371/journal.pone.0023319 e23319
247. Chiang C. Y., Huang M. H., Hsieh C. H., Dengue-1 envelope protein domain III along with PELC and CpG oligodeoxynucleotides synergistically enhances immune responses. PLOS Neglected Tropical Diseases 2012 6 5 10.1371/journal. pntd.0001645 e1645
248. Halstead S. B., Controversies in dengue pathogenesis. Paediatrics and International Child Health 2012 32 supplement 1 5 9 10.1179/2046904712Z. 00000000045
249. Thomas S. J., Endy T. P., Critical issues in dengue vaccine development. Current Opinion in Infectious Diseases 2011 24 5 442 450 2-s2.0-80052496440 10.1097/QCO.0b013e32834a1b0b
250. Brien J. D., Austin S. K., Sukupolvi-Petty S., O'Brien K. M., Johnson S., Fremont D. H., Diamond M. S., Genotype-specific neutralization and protection by antibodies against dengue virus type 3. Journal of Virology 2010 84 20 10630 10643 2-s2.0-77957192264 10.1128/JVI.01190-10
251. Bollati M., Alvarez K., Assenberg R., Baronti C., Canard B., Cook S., Coutard B., Decroly E., de Lamballerie X., Gould E. A., Grard G., Grimes J. M., Hilgenfeld R., Jansson A. M., Malet H., Mancini E. J., Mastrangelo E., Mattevi A., Milani M., Moureau G., Neyts J., Owens R. J., Ren J., Selisko B., Speroni S., Steuber H., Stuart D. I., Unge T., Bolognesi M., Structure and functionality in flavivirus NS-proteins: perspectives for drug design. Antiviral Research 2010 87 2 125 148 2-s2.0-77954956665 10.1016/j.antiviral.2009.11.009
252. Gould E. A., Solomon T., Mackenzie J. S., Does antiviral therapy have a role in the control of Japanese encephalitis? Antiviral Research 2008 78 1 140 149 2-s2.0-40749116583 10.1016/j.antiviral.2007.10.005 (Pubitemid 351395301)
253. Kinney R. M., Huang C. Y.-H., Rose B. C., Kroeker A. D., Dreher T. W., Iversen P. L., Stein D. A., Inhibition of dengue virus serotypes 1 to 4 in vero cell cultures with morpholino oligomers. Journal of Virology 2005 79 8 5116 5128 2-s2.0-16244366477 10.1128/JVI.79.8.5116-5128.2005 (Pubitemid 40464261)
254. Stein D. A., Huang C. Y.-H., Silengo S., Amantana A., Crumley S., Blouch R. E., Iversen P. L., Kinney R. M., Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 virus. Journal of Antimicrobial Chemotherapy 2008 62 3 555 565 2-s2.0-49649101361 10.1093/jac/dkn221
255. Kumar P., Wu H., McBride J. L., Jung K.-E., Hee Kim M., Davidson B. L., Kyung Lee S., Shankar P., Manjunath N., Transvascular delivery of small interfering RNA to the central nervous system. Nature 2007 448 7149 39 43 2-s2.0-34447114618 10.1038/nature05901 (Pubitemid 47037001)
256. Ray D., Shi P.-Y., Recent advances in flavivirus antiviral drug discovery and vaccine development. Recent Patents on Anti-Infective Drug Discovery 2006 1 1 45 55 2-s2.0-34748891739 10.2174/157489106775244055
257. Shigeta S., Mori S., Kodama E., Kodama J., Takahashi K., Yamase T., Broad spectrum anti-RNA virus activities of titanium and vanadium substituted polyoxotungstates. Antiviral Research 2003 58 3 265 271 2-s2.0-0038735360 10.1016/S0166-3542(03)00009-3 (Pubitemid 36589017)
258. Talarico L. B., Pujol C. A., Zibetti R. G. M., Faría P. C. S., Noseda M. D., Duarte M. E. R., Damonte E. B., The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell. Antiviral Research 2005 66 2-3 103 110 2-s2.0-19344365993 10.1016/j.antiviral.2005.02.001 (Pubitemid 40720115)
259. Ono L., Wollinger W., Rocco I. M., Coimbra T. L. M., Gorin P. A. J., Sierakowski M.-R., In vitro and in vivo antiviral properties of sulfated galactomannans against yellow fever virus (BeH111 strain) and dengue 1 virus (Hawaii strain). Antiviral Research 2003 60 3 201 208 2-s2.0-0344153732 10.1016/S0166-3542(03)00175-X (Pubitemid 37456868)
260. Leyssen P., Van Lommel A., Drosten C., Schmitz H., De Clercq E., Neyts J., A novel model for the study of the therapy of flavivirus infections using the Modoc virus. Virology 2001 279 1 27 37 2-s2.0-0035916001 10.1006/viro.2000.0723 (Pubitemid 34160996)
261. Leyssen P., Balzarini J., De Clercq E., Neyts J., The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase. Journal of Virology 2005 79 3 1943 1947 2-s2.0-13744258758 10.1128/JVI.79.3. 1943-1947.2005 (Pubitemid 40459141)
262. Morrey J. D., Smee D. F., Sidwell R. W., Tseng C., Identification of active antiviral compounds against a New York isolate of West Nile virus. Antiviral Research 2002 55 1 107 116 2-s2.0-0035997936 10.1016/S0166-3542(02) 00013-X (Pubitemid 34655646)
263. Huggins J. W., Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug. Reviews of Infectious Diseases 1989 11 S750 761 2-s2.0-0024672299
264. Huggins J. W., Robins R. K., Canonico P. G., Synergistic antiviral effects of ribavirin and the C-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunyaviruses, and arenaviruses. Antimicrobial Agents and Chemotherapy 1984 26 4 476 480 2-s2.0-0021168019 (Pubitemid 14018080)
265. Neyts J., Meerbach A., McKenna P., De Clercq E., Use of the yellow fever virus vaccine strain 17D for the study of strategies for the treatment of yellow fever virus infections. Antiviral Research 1996 30 2-3 125 132 2-s2.0-0029888393 10.1016/0166-3542(96)89697-5 (Pubitemid 26178132)
266. Malinoski F. J., Hasty S. E., Ussery M. A., Dalrymple J. M., Prophylactic ribavirin treatment of dengue type 1 infection in rhesus monkeys. Antiviral Research 1990 13 3 139 150 2-s2.0-0025213442 10.1016/0166-3542(90)90029-7 (Pubitemid 20107193)
267. Koff W. C., Pratt R. D., Elm J. L. Jr., Venkateshan C. N., Halstead S. B., Treatment of intracranial dengue virus infections in mice with a lipophilic derivative of ribavirin. Antimicrobial Agents and Chemotherapy 1983 24 1 134 136 2-s2.0-0020586998 (Pubitemid 13076192)
268. LaColla P., Sommadossi J. P., Methods and compositions for treating flaviviruses and pestiviruses. US6812219, 2004
269. Diamond M. S., Zachariah M., Harris E., Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA. Virology 2002 304 2 211 221 2-s2.0-0036934742 10.1006/viro.2002.1685
270. Sintchak M. D., Fleming M. A., Futer O., Raybuck S. A., Chambers S. P., Caron P. R., Murcko M. A., Wilson K. P., Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid. Cell 1996 85 6 921 930 2-s2.0-0029899127 10.1016/S0092-8674(00)81275-1 (Pubitemid 26192142)
271. Stamos D. P., Bethiel R. S., Prodrugs of carbamate inhibitors of IMPDH. US6825224, 2004
272. Nair V., Chi G., Shu Q., Julander J., Smee D. F., A heterocyclic molecule with significant activity against dengue virus. Bioorganic and Medicinal Chemistry Letters 2009 19 5 1425 1427 2-s2.0-60449109722 10.1016/j.bmcl.2009.01. 031
273. Zhang X. G., Mason P. W., Dubovi E. J., Xu X., Bourne N., Renshaw R. W., Block T. M., Birk A. V., Antiviral activity of geneticin against dengue virus. Antiviral Research 2009 83 1 21 27 2-s2.0-67349161336 10.1016/j.antiviral.2009. 02.204
274. Mastrangelo E., Pezzullo M., De Burghgraeve T., Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug. Journal of Antimicrobial Chemotherapy 2012 67 8 1884 1894 10.1093/jac/dks147
275. Kaptein S. J. F., De Burghgraeve T., Froeyen M., Pastorino B., Alen M. M. F., Mondotte J. A., Herdewijn P., Jacobs M., De Lamballerie X., Schols D., Gamarnik A. V., Sztaricskai F., Neyts J., A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitro. Antimicrobial Agents and Chemotherapy 2010 54 12 5269 5280 2-s2.0-78649647586 10.1128/AAC.00686-10
276. Benarroch D., Egloff M.-P., Mulard L., Guerreiro C., Romette J.-L., Canard B., A structural basis for the inhibition of the NS5 dengue virus mRNA 2′ -O-methyltransferase domain by ribavirin 5′ -triphosphate. Journal of Biological Chemistry 2004 279 34 35638 35643 2-s2.0-4143116991 10.1074/jbc.M400460200 (Pubitemid 39100566)
277. Julander J. G., Shafer K., Smee D. F., Morrey J. D., Furuta Y., Activity of T-705 in a hamster model of yellow fever virus infection in comparison with that of a chemically related compound, T-1106. Antimicrobial Agents and Chemotherapy 2009 53 1 202 209 2-s2.0-59749106534 10.1128/AAC.01074-08
278. Cheenpracha S., Karalai C., Ponglimanont C., Subhadhirasakul S., Tewtrakul S., Anti-HIV-1 protease activity of compounds from Boesenbergia pandurata. Bioorganic and Medicinal Chemistry 2006 14 6 1710 1714 2-s2.0-32044475345 10.1016/j.bmc.2005.10.019 (Pubitemid 43199504)